EMA licenses Mayzent for MS
admin 21st January 2020 Uncategorised 0Novartis also expects NICE and SMC decisions in the first half of 2020.
More: EMA licenses Mayzent for MS
Source: News
Novartis also expects NICE and SMC decisions in the first half of 2020.
More: EMA licenses Mayzent for MS
Source: News
Fierce Pharma Politics—Judge blocks Trump's 'most favored nation' drug pricing rule
Fierce Pharma Politics—Judge blocks Trump's 'most favored nation' d
Feds consider half-doses of Moderna COVID-19 vaccine to stretch supplies, as U.K. spaces out Pfizer, AstraZeneca shots
Feds consider half-doses of Moderna COVID-19 vaccine to stretch suppl
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 wit
© 1994 - 2021 B.M. Pharmaceuticals